Head-to-head · free
SURG vs Taiwan Semiconductor Manufacturing Company Limited
SURG vs TSM — return on capital, cash generation, margins and balance sheet side by side.
SURG
0 / 8
measures where SURG leads
TSM
8 / 8
measures where TSM leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SURG · FY2025 | TSM · FY2025 |
|---|---|---|
| Revenue | $57.0M | $3.85T |
| Net income | (36.1M) | $1.74T |
| Revenue growth (yearly, multi-year) | 2.8% | 24.8% |
| Free cash flow | (21.3M) | $992.4B |
| Free cash flow margin | -37.4% | 25.8% |
| Net cash / (debt) | — | $1.70T |
| ROIC | — | 26.3% |
| Return on equity | — | 35.4% |
| Gross margin | -18.6% | 59.9% |
| Operating margin | -53.8% | 50.8% |
| Net debt / EBITDA | -0.35x | -0.66x |
Figures are as reported by each company; latest fiscal year shown.
Where SURG's cash went (FY2025)
- Capital spending
- $18590
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Taiwan Semiconductor Manufacturing Company Limited's cash went (FY2025)
- Capital spending
- $1.28T
- Buybacks
- $0
- Dividends
- $466.8B
- Acquisitions
- $0
- Net debt issued / (repaid)
- $40.9B
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free